Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Historical Background and Scientific Context Scientific interest in synthetic peptides has expanded significantly with advances in molecular biology and biochemical research
The contract development and manufacturing organization (CDMO) Corden Pharma is among the drug makers doing so and has pledged to spend 900 million ($981 million) over the next three years to expedite GLP-1 drug production in Europe and the U.S
Methods Leveraging the target trial emulation framework, we conducted a retrospective study using observational data to emulate a new user, active comparator trial examining the effects of initiating GLP-1RA (exposure group) versus SGLT2 inhibitors (control group), with random treatment assignment emulated by propensity score matching with 1:1 ratio
Two of the currently approved medications to treat NPC disease represent disease-modifying therapeutics that delay neurodegeneration and disease progression rather than targeting the inability of NPC mutants to export cholesterol from LE/Lys
US$ 24.82
US$ 23.52
US$ 22.88
US$ 26.63
US$ 25.84
US$ 29.57
US$ 20.30
US$ 27.72
US$ 27.70
